Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Dent

Showing results (11-20 of 129) with videos related to

Pageof 13
Sort By:
Clinical Breast Cancer|November 30, 2019
Practical Treatment Strategies and Future Directions After Progression While Receiving CDK4/6 Inhibition and Endocrine Therapy in Advanced HR<sup>+</sup>/HER2<sup>-</sup> Breast CancerSarah Sammons, Mythili Shastry, Susan Dent, et al.
Cancer Treatment Reviews|February 26, 2013
HER2-targeted therapy in breast cancer: a systematic review of neoadjuvant trialsSusan Dent, Basak Oyan, Arnd Honig, et al.
Nuclear Medicine Communications|November 13, 2018
Diastolic dysfunction can precede systolic dysfunction on MUGA in cancer patients receiving trastuzumab-based therapyRan Klein, Doaa Nadouri, Erin Osler, et al.
JACC. Cardiooncology|October 31, 2024
Anthracycline Cardiotoxicity in Adult Cancer Patients: <i>JACC: CardioOncology</i> State-of-the-Art ReviewMassimiliano Camilli, Carlo Maria Cipolla, Susan Dent, et al.
Cancer Treatment Reviews|March 25, 2008
Metastatic breast cancer: the role of pegylated liposomal doxorubicin after conventional anthracyclinesShailendra Verma, Susan Dent, Benjamin J W Chow, et al.
European Journal of Cancer (Oxford, England : 1990)|August 18, 2014
Factors influencing Oncotype DX use in the management of early breast cancer: a single centre experienceXiaofu Zhu, Susan Dent, Lise Paquet, et al.
Case Reports in Oncological Medicine|December 23, 2014
Acute cardiogenic shock induced by infusional 5-FluorouracilJeffrey Sulpher, Franco Dattilo, Susan Dent, et al.
Breast Cancer Research and Treatment|May 21, 2024
Assessment of efficacy and safety of dose-dense doxorubicin and cyclophosphamide (ddAC) in combination with immunotherapy in early-stage triple-negative breast cancerOlivia White, Susan Dent, Kelly Westbrook, et al.
Frontiers in Cardiovascular Medicine|June 6, 2022
Cardiac Monitoring and Heart Failure in Advanced Breast Cancer Patients Treated With Trastuzumab in Ontario, CanadaMoira Rushton, Coralea Kappel, Isac Lima, et al.
CA: a Cancer Journal for Clinicians|February 27, 2016
Cardiotoxicity of anticancer treatments: Epidemiology, detection, and managementGiuseppe Curigliano, Daniela Cardinale, Susan Dent, et al.
Pageof 13

Showing results (11-20 of 129) with videos related to

Sort By:
Pageof 13
Clinical Breast Cancer|November 30, 2019
Practical Treatment Strategies and Future Directions After Progression While Receiving CDK4/6 Inhibition and Endocrine Therapy in Advanced HR<sup>+</sup>/HER2<sup>-</sup> Breast CancerSarah Sammons, Mythili Shastry, Susan Dent, et al.
Cancer Treatment Reviews|February 26, 2013
HER2-targeted therapy in breast cancer: a systematic review of neoadjuvant trialsSusan Dent, Basak Oyan, Arnd Honig, et al.
Nuclear Medicine Communications|November 13, 2018
Diastolic dysfunction can precede systolic dysfunction on MUGA in cancer patients receiving trastuzumab-based therapyRan Klein, Doaa Nadouri, Erin Osler, et al.
JACC. Cardiooncology|October 31, 2024
Anthracycline Cardiotoxicity in Adult Cancer Patients: <i>JACC: CardioOncology</i> State-of-the-Art ReviewMassimiliano Camilli, Carlo Maria Cipolla, Susan Dent, et al.
Cancer Treatment Reviews|March 25, 2008
Metastatic breast cancer: the role of pegylated liposomal doxorubicin after conventional anthracyclinesShailendra Verma, Susan Dent, Benjamin J W Chow, et al.
European Journal of Cancer (Oxford, England : 1990)|August 18, 2014
Factors influencing Oncotype DX use in the management of early breast cancer: a single centre experienceXiaofu Zhu, Susan Dent, Lise Paquet, et al.
Case Reports in Oncological Medicine|December 23, 2014
Acute cardiogenic shock induced by infusional 5-FluorouracilJeffrey Sulpher, Franco Dattilo, Susan Dent, et al.
Breast Cancer Research and Treatment|May 21, 2024
Assessment of efficacy and safety of dose-dense doxorubicin and cyclophosphamide (ddAC) in combination with immunotherapy in early-stage triple-negative breast cancerOlivia White, Susan Dent, Kelly Westbrook, et al.
Frontiers in Cardiovascular Medicine|June 6, 2022
Cardiac Monitoring and Heart Failure in Advanced Breast Cancer Patients Treated With Trastuzumab in Ontario, CanadaMoira Rushton, Coralea Kappel, Isac Lima, et al.
CA: a Cancer Journal for Clinicians|February 27, 2016
Cardiotoxicity of anticancer treatments: Epidemiology, detection, and managementGiuseppe Curigliano, Daniela Cardinale, Susan Dent, et al.
Pageof 13